Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 25, 1999
Predictive value of pattern VEP, pattern ERG and hole size in macular hole surgeryM A Tilanus, M H Cuypers, N A Bemelmans, et al.
Breast (Edinburgh, Scotland)|January 30, 2021
Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial riskH Amarens Geuzinge, Eveline A M Heijnsdijk, Inge-Marie Obdeijn, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2016
Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using modelsInge-Marie Obdeijn, Eveline A M Heijnsdijk, M G Myriam Hunink, et al.
Cancer Cytopathology|May 31, 2013
Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriersRadka D Georgieva, Inge M Obdeijn, Agnes Jager, et al.
The British Journal of Surgery|June 8, 2006
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancerM M A Tilanus-Linthorst, C Alves, C Seynaeve, et al.
Breast Cancer Research and Treatment|February 26, 2014
Should we screen BRCA1 mutation carriers only with MRI? A multicenter studyInge-Marie Obdeijn, Gonneke A O Winter-Warnars, Ritse M Mann, et al.
International Journal of Cancer|May 20, 2008
Breast cancer screening: evidence for false reassurance?Rianne de Gelder, Elisabeth van As, Madeleine M A Tilanus-Linthorst, et al.
International Journal of Cancer|September 9, 2017
Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patientsMirelle Lagendijk, Marissa C van Maaren, Sepideh Saadatmand, et al.
AJR. American Journal of Roentgenology|January 25, 2013
Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgeryInge-Marie Obdeijn, Madeleine M A Tilanus-Linthorst, Sandra Spronk, et al.
Oncotarget|September 4, 2018
Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancerMirelle Lagendijk, Sepideh Saadatmand, Linetta B Koppert, et al.
Pageof 6